Julia M. Jansen
Marburg An Der Lahn, HE 35043, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Prostacyclin Released by Cancer-Associated Fibroblasts Promotes Immunosuppressive and Pro-Metastatic Macrophage Polarization in the Ovarian Cancer Microenvironment.
Journal: Cancers
Published: November 22, 2022
The multicellular signalling network of ovarian cancer metastases.
Journal: Clinical and translational medicine
Published: July 29, 2021
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion.
Journal: Molecular oncology
Published: March 19, 2020
Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C.
Journal: Cell death & disease
Published: December 02, 2019
Multi-platform Affinity Proteomics Identify Proteins Linked to Metastasis and Immune Suppression in Ovarian Cancer Plasma.
Journal: Frontiers in oncology
Published: August 14, 2019
Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment.
Journal: Theranostics
Published: June 12, 2019
Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
Journal: Molecular oncology
Published: September 01, 2018
Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells.
Journal: Oncoimmunology
Published: September 22, 2017
Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation.
Journal: Oncoimmunology
Published: March 08, 2017
A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.
Journal: Genome biology
Published: December 17, 2015
Last Updated: 09/26/2026